Literature DB >> 11451621

Hormone replacement therapy increases ACTH/dehydroepiandrosterone sulfate in menopause.

E Fonseca1, L Basurto, S Velázquez, A Zárate.   

Abstract

OBJECTIVE: To demonstrate that hypoestrogenism in menopause is in part responsible for the decrease in circulating dehydroepiandrosterone sulfate (DHEA-S) and ACTH levels. To test this hypothesis, 25 postmenopausal women aged 47-60 years, were given orally conjugated equine estrogen (CEE) to study the effect on circulating DHEA-S, cortisol and ACTH.
DESIGN: A prospective, non-blinded study was performed. Hormonal levels were analyzed before and after three cycles of CEE 0.625 mg/day for 21 days followed each by chlormadinone acetate for 5 days.
RESULTS: Low baseline levels of DHEA-S increased significantly after HRT (1.71+/-0.75 to 3.3+/-1.5 micromol/l, (P<0.001). ACTH levels augmented moderately from 3.26+/-1.4 to 4.7+/-1.8 pmol/l (P<0.05) and cortisol from 350.4+/-118 to 450.8+/-144 nmol/l (P<0.01). A positive correlation was obtained between 17 beta-estradiol and ACTH (r=0.48), estradiol and cortisol (r=0.52) as well as estradiol and DHEA-S (r=0.60). In addition, the correlation was highly significant (P<0.001) between ACTH and DHEA-S at the term of HRT.
CONCLUSION: HRT increased DHEA-S, ACTH and cortisol concentrations, which may suggest that this therapy may exert a stimulatory effect on the pituitary gland when baseline hypoestrogenism is present, but further studies are required to clarify the mechanism underlying this process.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11451621     DOI: 10.1016/s0378-5122(01)00192-x

Source DB:  PubMed          Journal:  Maturitas        ISSN: 0378-5122            Impact factor:   4.342


  6 in total

1.  Luteal-phase accentuation of acoustic startle response in women with premenstrual dysphoric disorder.

Authors:  Cynthia Neill Epperson; Brian Pittman; Kathryn Ann Czarkowski; Stephanie Stiklus; John Harrison Krystal; Christian Grillon
Journal:  Neuropsychopharmacology       Date:  2007-02-21       Impact factor: 7.853

2.  Differential regulation of dehydroepiandrosterone and estrogen on bone and uterus in ovariectomized mice.

Authors:  L Wang; Y-D Wang; W-J Wang; D-J Li
Journal:  Osteoporos Int       Date:  2008-08-09       Impact factor: 4.507

3.  Photoperiodic modulation of adrenal gland function in the rhesus macaque: effect on 24-h plasma cortisol and dehydroepiandrosterone sulfate rhythms and adrenal gland gene expression.

Authors:  Dario R Lemos; Jodi L Downs; Martin N Raitiere; Henryk F Urbanski
Journal:  J Endocrinol       Date:  2009-02-17       Impact factor: 4.286

4.  Tamoxifen is an estrogen antagonist on gonadotropin secretion and responsiveness of the hypothalamic-pituitary- adrenal axis in female monkeys.

Authors:  M E Wilson; D Mook; F Graves; J Felger; I F Bielsky; K Wallen
Journal:  Endocrine       Date:  2003-12       Impact factor: 3.633

5.  Effects of estrogen versus estrogen and progesterone on cortisol and interleukin-6.

Authors:  Kate M Edwards; Paul J Mills
Journal:  Maturitas       Date:  2008-11-17       Impact factor: 4.342

6.  Regulation of gonadotropins by corticotropin-releasing factor and urocortin.

Authors:  Kazunori Kageyama
Journal:  Front Endocrinol (Lausanne)       Date:  2013-02-20       Impact factor: 5.555

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.